نتائج البحث - "Muscarinic Antagonists"

المصدر: International Journal of Chronic Obstructive Pulmonary Disease, 15, 2739-2750. DOVE MEDICAL PRESS LTD
International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, medicine.medical_specialty, real-world, Exacerbation, comparative effectiveness, Socio-culturale, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Rate ratio, chronic obstructive pulmonary disease, Cohort Studies, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Maintenance therapy, Internal medicine, Formoterol Fumarate, Administration, Inhalation, Medicine, comp, Humans, 030212 general & internal medicine, observational, Adrenergic beta-2 Receptor Agonists, Original Research, Aged, COPD, biology, business.industry, Chronic obstructive pulmonary disease, comp,rative effectiveness. electronic health records, heterogeneity, observational, real-world, Beclomethasone, rative effectiveness. electronic health records, General Medicine, Beclometasone dipropionate, Lama, medicine.disease, biology.organism_classification, Bronchodilator Agents, Pneumonia, electronic health records, 030228 respiratory system, heterogeneity, business, medicine.drug

وصف الملف: text/html; application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c53da00a1eec2aee487da506b0bbe583Test
https://www.dovepress.com/extrafine-beclometasone-dipropionateformoterol-fumarate-vs-double-bron-peer-reviewed-article-COPDTest

7

Clinically Important Deterioration Among Patients with Chronic Obstructive Pulmonary Disease (COPD) Treated with Nebulized Glycopyrrolate: A Post Hoc Analysis of Pooled Data from Two Randomized, Double-Blind, Placebo-Controlled Studies

المؤلفون: Xiaoli Niu, Lindsey Murray, Carole Dembek, Edward Kerwin

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: medicine.medical_specialty, composite measure, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Placebo, Gastroenterology, Severity of Illness Index, 03 medical and health sciences, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Double-Blind Method, Internal medicine, Forced Expiratory Volume, Post-hoc analysis, Administration, Inhalation, medicine, Humans, 030212 general & internal medicine, Respiratory system, Glycopyrrolate, Aged, Original Research, clinically important deterioration, COPD, business.industry, General Medicine, Odds ratio, medicine.disease, Confidence interval, Bronchodilator Agents, Nebulizer, Treatment Outcome, 030228 respiratory system, nebulized glycopyrrolate, Disease Progression, Female, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae661cd917e15d264aafb9e8668a9f01Test
https://www.dovepress.com/clinically-important-deterioration-among-patients-with-chronic-obstruc-peer-reviewed-article-COPDTest

8

Effectiveness and Tolerability of LABA/LAMA Fixed-Dose Combinations Aclidinium/Formoterol, Glycopyrronium/Indacaterol and Umeclidinium/Vilanterol in the Treatment of COPD in Daily Practice – Results of the Non-Interventional DETECT Study

المؤلفون: Felix W Friedrich, Tanja Plate, Jutta Beier

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b10cca0047d1f1f364a60115e8c7b501Test
https://www.dovepress.com/effectiveness-and-tolerability-of-labalama-fixed-dose-combinations-acl-peer-reviewed-article-COPDTest

9

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD

المؤلفون: Gary T. Ferguson, Robert Mróz, Diana Jarreta, Rosa Segarra, Esther Garcia Gil, Edward Kerwin, Henrik Watz, Eduard Molins, Sanjay Sethi

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Spirometry, medicine.medical_specialty, Time Factors, Vital Capacity, LABA, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Severity of Illness Index, aclidinium bromide, Gastroenterology, Pulmonary Disease, Chronic Obstructive, Aclidinium bromide, Double-Blind Method, Forced Expiratory Volume, Formoterol Fumarate, Internal medicine, medicine, Humans, In patient, Israel, Tiotropium Bromide, Adrenergic beta-2 Receptor Agonists, Lung, Lung function, Aged, Original Research, Morning, COPD, medicine.diagnostic_test, business.industry, LAMA, technology, industry, and agriculture, Area under the curve, Recovery of Function, General Medicine, Middle Aged, medicine.disease, United States, Bronchodilator Agents, bronchodilators, Europe, Drug Combinations, Treatment Outcome, Copd assessment test, Female, business, 24-hour lung function, Tropanes

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b358dc3b16529986e033713622fc45b8Test
https://www.dovepress.com/amplify-a-randomized-phase-iii-study-evaluating-the-efficacy-and-safet-peer-reviewed-article-COPDTest

10

Efficacy and safety of a novel, nebulized glycopyrrolate for the treatment of COPD: effect of baseline disease severity and age; pooled analysis of GOLDEN 3 and GOLDEN 4

المؤلفون: Jill A. Ohar, Thomas Goodin, Shahin Sanjar, Robert Tosiello

المصدر: International Journal of Chronic Obstructive Pulmonary Disease

مصطلحات موضوعية: Male, Time Factors, Health Status, Gastroenterology, Severity of Illness Index, Pulmonary Disease, Chronic Obstructive, 0302 clinical medicine, Forced Expiratory Volume, Medicine, 030212 general & internal medicine, Lung, Original Research, Randomized Controlled Trials as Topic, Aged, 80 and over, COPD, biology, Incidence (epidemiology), LAMA, Age Factors, General Medicine, Lama, Middle Aged, Bronchodilator Agents, Treatment Outcome, disease severity, Female, Adult, medicine.medical_specialty, nebulizer, Muscarinic Antagonists, International Journal of Chronic Obstructive Pulmonary Disease, Placebo, Drug Administration Schedule, 03 medical and health sciences, Internal medicine, Severity of illness, Administration, Inhalation, long-acting muscarinic antagonist, Humans, Adverse effect, Glycopyrrolate, Aged, business.industry, Nebulizers and Vaporizers, Recovery of Function, medicine.disease, biology.organism_classification, Clinical trial, 030228 respiratory system, age, Clinical Trials, Phase III as Topic, nebulized glycopyrrolate, business

وصف الملف: text/html

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cdaa1b2bea751017c972c297212c19f8Test
https://www.dovepress.com/efficacy-and-safety-of-a-novel-nebulized-glycopyrrolate-for-the-treatm-peer-reviewed-article-COPDTest

تنقيح النتائج